These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31335808)

  • 1. Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth.
    Wang Y; Brummel SS; Beilstein-Wedel E; Dagnall CL; Hazra R; Kacanek D; Chadwick EG; Marsit CJ; Chanock SJ; Savage SA; Poirier MC; Machiela MJ; Engels EA;
    AIDS; 2019 Nov; 33(13):2091-2096. PubMed ID: 31335808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
    Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
    J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
    Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Landay AL; Baker R; Stek AM; Khoury MM; Proia LA; Kessler HA; Sha BE; Tarone RE; Poirier MC
    AIDS; 1999 May; 13(8):919-25. PubMed ID: 10371172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV.
    Witt KL; Cunningham CK; Patterson KB; Kissling GE; Dertinger SD; Livingston E; Bishop JB
    Environ Mol Mutagen; 2007; 48(3-4):322-9. PubMed ID: 17358032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
    Lin SH; Wang Y; Hartley SW; Karyadi DM; Lee OW; Zhu B; Zhou W; Brown DW; Beilstein-Wedel E; Hazra R; Kacanek D; Chadwick EG; Marsit CJ; Poirier MC; Brummel SS; Chanock SJ; Engels EA; Machiela MJ;
    AIDS; 2021 Aug; 35(10):1525-1535. PubMed ID: 33756513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys.
    Olivero OA; Fernandez JJ; Antiochos BB; Wagner JL; St Claire ME; Poirier MC
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):323-9. PubMed ID: 11917235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
    Poirier MC; Divi RL; Al-Harthi L; Olivero OA; Nguyen V; Walker B; Landay AL; Walker VE; Charurat M; Blattner WA;
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):175-83. PubMed ID: 12794551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
    Vannappagari V; Koram N; Albano J; Tilson H; Gee C
    BJOG; 2016 May; 123(6):910-6. PubMed ID: 26269220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.
    Imam T; Jitratkosol MH; Soudeyns H; Sattha B; Gadawski I; Maan E; Forbes JC; Alimenti A; Lapointe N; Lamarre V; Money DM; Côté HC;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):495-502. PubMed ID: 22580562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.
    Demas PA; Webber MP; Schoenbaum EE; Weedon J; McWayne J; Enriquez E; Bamji M; Lambert G; Thea DM
    Pediatrics; 2002 Sep; 110(3):e35. PubMed ID: 12205285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.